Disturbances of the combustion processes in muscular disorders IRENA NIEBROJ-DOBOSZ From the Department ofNeurology, School of Medicine, Warsaw, Poland Attempts to elucidate carbohydrate metabolism in muscular diseases have been made by a relatively large number of authors but the results obtained, often contradictory, seem to be difficult to classify in a cycle of metabolic disorders. Nevertheless disturbances of carbohydrate metabolism appear to play an important role in the pathogenesis of muscular diseases. In view of the key position of pyruvic acid in the metabolic processes, it seemed interesting to investigate further its metabolism, all the more so, as the literature suggests that the blood pyruvic acid level is raised in progressive muscular dystrophy.
METHODS AND MATERIAL
With the subjects fasting, blood was sampled without venous stasis. The proteins were precipitated with trichloroacetic acid, and the following determinations were made on the filtrates. Pyruvic acid was determined by the method of Friedemann and Haugen (1943) . Lactic acid determinations were carried out by the method described by Greig (1947) . Citric acid was determined after removing interfering substances by the method of Beutler and Yeh (1959) . x-Ketoglutaric acid was determined by the method of Keil and Sormova (1959) . Oxalacetic acid was determined by the method of Friedemann and Haugen (1943) alter converting into pyruvic acid by means ofcitrate aniline. Blood glucose was determined by the method of Hagedorn and Jensen (1923) . Serum glutamic-oxalacetic and glutamic-pyruvic transaminase activity was determined by the method of Reitman and Frankel (1957) . Creatine and creatinine were determined in the blood by the method of Brod and Sirota (1948) and in urine by the method of Bonsnes and Taussky (1945) . Biopsy specimens of muscle were obtained under local anaesthesia (0-5 % novocaine) and prepared for determination of the content of the pyruvic and citric acid by the method of Taussky, Washington, Zubillaga, and Milhorat (1962) . Non-collagen nitrogen in the muscular homogenates was determined by the method of Pamas and Wagner (1921) .
A group of 130 patients with muscular disorders characterized by muscular atrophy was studied; it included 70 patients with progressive muscular dystrophy. (Fig. 2) . This was lowered in progressive muscular dystrophy in contrast to the values in other types of muscular disorders. The difference is statistically significant at a significance level of 1 %. In Fig. 2 the level of citric acid below 1-5 mg. per 100 ml. in certain cases first diagnosed as congenital myopathy or spinal atrophy is related to cases which later also appeared to be of muscular dystrophy. In none of the groups of muscular disorders studied was there any change in the blood concentration of glucose.
Attempts at correlating the degree of change (Luzzatto and Ramelli, 1959) Id in progressive may be due either to the excessive production, resulting from increased oxidation of, in the first place, the carbohydrates, or to the blocking of the rophy with the process by which pyruvic acid is transferred into the [ism of creatine citric cycle pathway. The results obtained in proot reveal any gressive muscular dystrophy, hyperpyruvicaemia with a definite fall in blood citric acid level, might mninase activity be due to the blocking of the process by means of o a decrease in which pyruvic acid is transferred into the Krebs However, it is cycle pathway, or to the inability of the organism to lation (correla-compensate for the probable scarcity of some citric for SGPT = cycle metabolites caused by their utilization in other metabolic processes. The latter possibility is imLnd citric acid probable. A compensating influence is that of the of 10 patients transaminases, the activity of which is raised in a y and of six large percentage of patients with progressive wasting. The muscular dystrophy. Also the elevation of malic al persons. In acid dehydrogenase activity in these cases indicates muscular con-compensation of some stages of the citric cycle (Coletta, Berni Canani, Rea, Schettini, and Cigala, 1962; Schettini, Rea, and Canani, 1961) . The normal a-ketoglutaric and oxalacetic acid levels likewise provide evidence in favour of compensation for citric acid and further links ofthe citric cycle. It seems probable that oxidative decarboxylation is impaired. Simple and oxidative carboxylations, the remaining routes of introducing pyruvic acid into the citric cycle, may, however, be insufficient for oxidation of the excess of pyruvic acid, which is not only derived from carbohydrate metabolism. In muscular disorders of different types changes in the blood pyruvic acid content seem to be due only to an increased oxidation of carbohydrates or possibly of proteins.
The blood pyruvic acid content does not provide a full picture of the situation at the site of the muscle. For this reason, it was considered of interest to compare pyruvic and citric acid levels in blood with those in muscle. In accordance with the results of Lilienthal, Zierler, Folk, and Riley (1950) , the reference base selected was non-collagen nitrogen. Pyruvic acid level in the muscle of dystrophics was normal but it should be kept in mind that a fall in the activity of glycogenolytic enzymes in muscle is not, as is known from the studies of Ronzoni, Berg, and Landau (1960) , a factor limiting carbohydrate metabolism. Thus, decreased activity of glycogenolytic enzymes would not play the role of an agent limiting production of pyruvic acid. The normal citric acid level in the muscle in progressive muscular dystrophy confirms the normal function of the enzymes regulating the system of final combustion processes. Thus, inhibition of the oxidation processes does not take place in muscle.
An analysis of the group of subjects with progressive muscular dystrophy with reference to the patient's age, the type of dystrophy, duration of the disease, and severity of the course will be the subject of a separate report.
SUMMARY
In 130 cases of different kinds of muscular disease pyruvic and citric acid levels in the blood were determined; in 50 patients of this group the blood levels of lactic, a-ketoglutaric, and oxalacetic acids were determined. In cases of progressive muscular dystrophy there was a statistically significant fall in the blood citric acid content, with a concomitant hyperpyruvicaemia. In other types of neuromuscular disorder only the blood pyruvic acid level was increased. There were no characteristic changes found in other tricarboxylic acids or lactic acid in any of the groups of muscular diseases. In progressive muscular dystrophy there were no changes in pyruvic acid and citric acid levels in muscle as compared with other muscular diseases and with normal values. A possible mechanism of these changes is discussed.
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